You can watch PHIOW and buy or sell other stocks, options, and ETFs commission-free!
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. Read More The company was founded on September 8, 2011 and is headquartered in Marlborough, MA. The listed name for PHIOW is Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021.
52 Week High
52 Week Low